Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain

Developmental Brain Research

Volumn 104, Issue 1-2, 1997, Pages 209-213

  McGrath, K E ^a   Seidler, F J ^a   Slotkin, T A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain development; Cocaine; Dexamethasone; Glucocorticoid; Paroxetine; Serotonin; Transpo rter

Indexed keywords

COCAINE; DEXAMETHASONE; GLUCOCORTICOID; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN DEVELOPMENT; CONTROLLED STUDY; FETUS; GENE EXPRESSION REGULATION; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; TERATOGENESIS;

ANIMALS; BRAIN; CARRIER PROTEINS; COCAINE; DEXAMETHASONE; EMBRYONIC AND FETAL DEVELOPMENT; GLUCOCORTICOIDS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA;

EID: 0031578872     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(97)00144-2     Document Type: Article

References (50)

1. [1] H.M. Akbari, H.K. Kramer, P.M. Whitaker-Azmitia, L.P. Spear, E.G. Azmitia, Prenatal cocaine exposure disrupts the development of the serotonergic system, Brain Res. 572 (1992) 57-63.
2. [2] T. Anderson-Brown, T.A. Slotkin, F.J. Seidler, Cocaine acutely inhibits DNA synthesis in developing rat brain regions: evidence for direct actions, Brain Res. 537 (1990) 197-202.
3. [3] M.C. Bohn, Glucocorticoid induced teratologies of the nervous system, in: J. Yanai (Eds.), Neurobehavioral Teratology, Elsevier, Amsterdam, 1984, pp. 365-387.
4. [4] J. Borrell, I. Lloréns, S. Borrell, Adrenal, plasma and urinary corticosteroids during single or repeated administration of morphine in cats, Eur. J. Pharmacol. 31 (1975) 237-242.
5. [5] G.R. Cam, J.R. Bassett, K.D. Cairncross, The action of nicotine on the pituitary-adrenal cortical axis, Arch. Int. Pharmacodyn. Ther. 237 (1979) 49-66.
6. [6] V. Cuomo, Perinatal neurotoxicology of psychotropic drugs, Trends Pharmacol. Sci. 8 (1987) 346-350.
7. [7] D.L. Dow-Edwards, Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy, Ann. NY Acad. Sci. 562 (1989) 280-289.
8. [8] D.L. Dow-Edwards, Modification of acoustic startle reactivity by cocaine administration during the postnatal period: comparison with a specific serotonin reuptake inhibitor, Neurotoxicol. Teratol. 18 (1996) 289-296.
9. [9] E.M. Factor, R.P. Hart, G.M. Jonakait, Neurochemical development of the raphe after continuous prenatal cocaine exposure, Brain Res. Bull. 31 (1993) 49-56.
10. 3H]cyanoimipramine for quantitative measurement of serotonin transporter sites in human brain, Neuropsychopharmacology 14 (1996) 309-323.
11. 3H]paroxetine binding to rat cortical membranes, Eur. J. Pharmacol. 118 (1985) 107-114.
12. [12] M. Hamon, S. Bourgoin, C. Chanez, F. De Vitry, Do serotonin and other neurotransmitters exert a trophic influence on the immature brain?, Dev. Neurobiol. 12 (1989) 171-183.
13. [13] J.A. King, M. Davila-Garcia, E.C. Azmitia, F.L. Strand, Differential effects of prenatal and postnatal ACTH or nicotine exposure on 5-HT high affinity uptake in the neonatal rat brain, Int. J. Dev. Neurosci. 9 (1991) 281-286.
14. [14] S.M. Koegler, F.J. Seidler, J.R. Spencer, T.A. Slotkin, Ischemia contributes to adverse effects of cocaine on brain development: suppression of ornithine decarboxylase activity in neonatal rat, Brain Res. Bull. 27 (1991) 829-834.
15. [15] J.M. Lauder, Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods, in: M. Marois (Eds.), Prevention of Physical and Mental Congenital Defects, Alan R. Liss, New York, 1985, pp. 375-380.
16. [16] J.M. Lauder, H. Krebs, Serotonin as a differentiation signal in early neurogenesis, Dev. Neurosci. 1 (1978) 15-30.
17. [17] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-270.
18. [18] M.P. Mahalik, R.F. Gautieri, D.E. Mann Jr., Mechanisms of cocaine-induced teratogenesis, Res. Comm. Subst. Abuse 5 (1984) 279-302.
19. [19] J.S. Meyer, L.P. Shearman, L.M. Collins, Monoamine transporters and the neurobehavioral teratology of cocaine, Pharmacol. Biochem. Behav. 55 (1996) 585-593.
20. [20] J.S. Meyer, L.P. Shearman, L.M. Collins, R.L. Maguire, Cocaine binding sites in fetal rat brain: implications for prenatal cocaine action, Psychopharmacology 112 (1993) 445-451.
21. [21] R.L. Moldow, A.J. Fischman, Cocaine induced secretion of ACTH, β-endorphin and corticosterone, Peptides 8 (1987) 819-822.
22. 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotonergic innervation in the rat, Psychiat. Res. 38 (1991) 97-104.
23. [23] H.A. Navarro, E.M. Kudlacz, J.P. Eylers, T.A. Slotkin, Prenatal dexamethasone administration disrupts the pattern of cellular development in rat lung, Teratology 40 (1989) 433-438.
24. [24] H.A. Navarro, J. Lachowicz, J. Bartolome, W.L. Whitmore, T.A. Slotkin, Effects of prenatal dexamethasone on development of ornithine decarboxylase activity in brain and peripheral tissues of rats, Pediatr. Res. 24 (1988) 465-469.
25. [25] G.D. Olsen, Potential mechanisms of cocaine-induced developmental neurotoxicity: a minireview, Neurotoxicology 16 (1995) 159-167.
26. [26] J.R. Owiny, M.T. Jones, D. Sadowsky, T. Myers, A. Massmann, P.W. Nathanielsz, Cocaine in pregnancy: the effect of maternal administration of cocaine on the maternal and fetal pituitary-adrenal axis, Am. J. Obstet. Gynecol. 164 (1991) 658-663.
27. [27] R.E. Poland, P. Lutchman-Singh, D. Au, S. McGeoy, M. Que, S. Acosta, J.T. McCracken, Exposure to threshold doses of nicotine in utero: 3. Augmentation of the prolactin and ACTH response to 8-OH DPAT by desipramine treatment is compromised in adult male offspring, Neurotoxicology 17 (1996) 351-358.
28. [28] F. Rougepont, M. Marinelli, M. LeMoal, H. Simon, P.V. Piazza, Stress-induced sensitization and glucocorticoids: 2. sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion, J. Neurosci. 15 (1995) 7189-7195.
29. [29] R.P. Rubin, W. Warner, Nicotine-induced stimulation of steroidogenesis in adrenocortical cells of the cat, Br. J. Pharmacol. 53 (1975) 357-362.
30. [30] F.J. Seidler, T.A. Slotkin, Prenatal cocaine and cell development in rat brain regions: effects on ornithine decarboxylase and macro-molecules, Brain Res. Bull. 30 (1993) 91-99.
31. [31] L.P. Shearman, L.M. Collins, J.S. Meyer, Characterization and localization of [I-125]RTI-55-labeled cocaine binding sites in fetal and adult rat brain, J. Pharmacol. Exp. Ther. 277 (1996) 1770-1783.
32. [32] R.K. Siegel, Cocaine smoking, J. Psychoactive Drugs 14 (1982) 271-359.
33. [33] J.W. Simpkins, F.P. Field, G. Torosian, E.E. Soltis, Effects of prenatal exposure to tricyclic antidepressants on adrenergic responses in progeny, Dev. Pharmacol. Ther. 8 (1985) 17-33.
34. [34] T.A. Slotkin, G. Barnes, C. Lau, F.J. Seidler, P. Trepanier, S.J. Weigel, W.L. Whitmore, Development of polyamine and biogenic amine systems in brains and hearts of neonatal rats given dexamethasone: role of biochemical alterations in cellular maturation for producing deficits in ontogeny of neurotransmitter levels, uptake, storage and turnover, J. Pharmacol. Exp. Ther. 221 (1982) 686-693.
35. [35] T.A. Slotkin, G.A. Barnes, E.C. McCook, F.J. Seidler, Programming of brainstem serotonin transporter development by prenatal glucocorticoids, Dev. Brain Res. 93 (1996) 155-161.
36. [36] T.A. Slotkin, S.E. Lappi, E.C. McCook, M.I. Tayyeb, J.P. Eylers, F.J. Seidler, Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity, Biol. Neonate 61 (1992) 326-336.
37. 3H]desmethylimipramine binding sites after fetal exposure to dexamethasone, Res. Comm. Chem. Pathol. Pharmacol. 73 (1991) 3-19.
38. [38] T.A. Slotkin, E.C. McCook, J.C. Ritchie, B.J. Carroll, F.J. Seidler, Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects, Biol. Psychiatry 41 (1997) 172-183.
39. [39] T.A. Slotkin, E.C. McCook, J.C. Ritchie, F.J. Seidler, Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model, Biol. Psychiatry 40 (1996) 576-684.
40. [40] T.A. Slotkin, E.C. McCook, F.J. Seidler, Glucocorticoids regulate the development of intracellular signaling: enhanced forebrain adenylate cyclase catalytic subunit activity after fetal dexamethasone exposure, Brain Res. Bull. 32 (1993) 359-364.
41. [41] T.A. Slotkin, F.J. Seidler, RJ.. Kavlock, J.V. Bartolome, Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: effects on DNA and protein in whole tissues, Teratology 43 (1991) 301-306.
42. [42] T.A. Slotkin, W.L. Whitmore, M. Salvaggio, F.J. Seidler, Perinatal methadone addiction affects brain synaptic development of biogenic amine systems in the rat, Life Sci. 24 (1979) 1223-1230.
43. [43] A.M. Snyder-Keller, R.W. Keller, Prenatal cocaine increases striatal serotonin innervation without altering the patch/matrix organization of intrinsic cell types, Dev. Brain Res. 74 (1993) 261-267.
44. [44] L.P. Spear, N.A. Frambes, C.L. Kirstein, Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats, Psychopharmacology 97 (1989) 427-431.
45. [45] L.P. Spear, C.L. Kirstein, N.A. Frambes, Cocaine effects on the developing nervous system: behavioral, psychopharmacological and neurochemical studies, Ann. NY Acad. Sci. 562 (1989) 290-307.
46. [46] S.R. Tonge, Catecholamine concentrations in discrete areas of the rat brain after the pre- and neonatal administration of phencyclidine and imipramine, J. Pharm. Pharmacol. 25 (1973) 164-166.
47. [47] K. Turlejski, Evolutionary ancient roles of serotonin: long-lasting regulation of activity and development, Acta Neurobiol. Exp. 56 (1996) 619-636.
48. [48] D.M. Turner, The role of adrenal catecholamines in the release of corticosterone and fatty acids by nicotine in the rat, Res. Comm. Chem. Pathol. Pharmacol. 12 (1975) 645-655.
49. [49] X.H. Wang, P. Levitt, A.O. Jenkins, E.H. Murphy, Normal development of tyrosine hydroxylase and serotonin immunoreactive fibers innervating anterior cingulate cortex and visual cortex in rabbits exposed prenatally to cocaine, Brain Res. 715 (1996) 221-224.
50. [50] P.M. Whitaker-Azmitia, Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology, Pharmacol. Rev. 43 (1991) 553-561.